Ghana has recorded two new variants of the Covid-19 virus, a cancer research company, Yemaachi Biotech has revealed.
According to the company, the new variants is of much concern.
The company revealed this on the official Twitter page explaining that the two variants, B.1 and B.1.525 have been in circulation in Ghana since March 2020.
The company further explained that the B.1 variant, first identified in Morocco and Algeria has been linked to increased transmissibility.
Speaking on the new variants, an immunologist and Research Fellow at the West Africa Centre for Cell Biology of Infectious Pathogens (WACCBIP) at the University of Ghana, Dr Yaw Bediako, said the B.1 variant has not shown any signs of being able to breach the vaccine-induced immunity.
“Currently there is no evidence that this variant is capable of evading vaccine-induced immunity. We must keep vaccinating at a high rate to minimize the likelihood that such a variant will emerge,” he said.
He indicated that the B.1.525 is more prevalent in the Northern and Western regions of Ghana.
He said the variant has mutations that may allow the virus to partly evade the immune system.